Document Type: Original Article
Education Development Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Gastrointestinal Cancers Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Vice Chancellery for Research and Technology, Mazandaran University of Medical Sciences, Sari, Iran
Research Center for Evidence-based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Community Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
Introduction: Evidence synthesis about economic analysis of cancer control and management in Iran was inconsistent.
Objective: The objective of this scoping review was to examine and map the rang of studies acknowledged this issue in Iran.
Methods: Several databases such as Cochrane Library, PubMed, ProQuest، Embase، and Google Scholar have been searched with relevant search strategy. Studies published from January 1, 2000, to January 1, 2017 were examined.
Results: Finally, forty-four articles were deemed appropriate for this study and were analyzed. Twenty-three studies had performed cost analysis, twelve cost-utility analysis (CUA), eight cost-effectiveness analysis (CEA), and only one cost-minimizing analysis. In only six articles the total cost (direct and indirect) had been evaluated. The incremental cost-effectiveness ratio (ICER) index had been measured in all eight articles on CEA. In studies on CUA, only one case had considered the disability adjusted life years (DALY) index.
Conclusion: After cost analysis which is highly popular, researchers in the field of cancer economy in Iran are often interested in CEA studies and, consequently, CUA ones. Results of the present study indicate that most analyses in this field have employed appropriate methodology, leading to accurate estimations of ICER in which can be used for appropriate meta-analysis in near future.